These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 3128650)

  • 1. Cost effectiveness of HemoQuant versus Hemoccult for colorectal cancer screening.
    Joseph AM; Crowson TW; Rich EC
    J Gen Intern Med; 1988; 3(2):132-8. PubMed ID: 3128650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the specificity and sensitivity of Hemoccult and HemoQuant in screening for colorectal neoplasia.
    St John DJ; Young GP; McHutchison JG; Deacon MC; Alexeyeff MA
    Ann Intern Med; 1992 Sep; 117(5):376-82. PubMed ID: 1503328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests.
    Ahlquist DA; Wieand HS; Moertel CG; McGill DB; Loprinzi CL; O'Connell MJ; Mailliard JA; Gerstner JB; Pandya K; Ellefson RD
    JAMA; 1993 Mar; 269(10):1262-7. PubMed ID: 8437303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of occult bleeding in asymptomatic colorectal cancer.
    Ahlquist DA; McGill DB; Fleming JL; Schwartz S; Wieand HS; Rubin J; Moertel CG
    Cancer; 1989 May; 63(9):1826-30. PubMed ID: 2702590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer screening.
    Applegate WB; Spector MH
    J Community Health; 1981; 7(2):138-51. PubMed ID: 7328198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost benefits of hemoccult screening for colorectal carcinoma.
    Allison JE; Feldman R
    Dig Dis Sci; 1985 Sep; 30(9):860-5. PubMed ID: 3928287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of eight fecal occult blood tests and HemoQuant in patients in whom colonoscopy is indicated.
    Gopalswamy N; Stelling HP; Markert RJ; Maimon HN; Wahlen SD; Haddy RI
    Arch Fam Med; 1994 Dec; 3(12):1043-8. PubMed ID: 7804488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occult-blood screening for colorectal carcinoma: the yield and the costs.
    Frank JW
    Am J Prev Med; 1985; 1(5):18-24. PubMed ID: 3939711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for colorectal cancer in a high-risk population. Results of a mathematical model.
    Eddy DM; Nugent FW; Eddy JF; Coller J; Gilbertsen V; Gottlieb LS; Rice R; Sherlock P; Winawer S
    Gastroenterology; 1987 Mar; 92(3):682-92. PubMed ID: 3102307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of new occult blood tests for detection of colorectal neoplasia.
    St John DJ; Young GP; Alexeyeff MA; Deacon MC; Cuthbertson AM; Macrae FA; Penfold JC
    Gastroenterology; 1993 Jun; 104(6):1661-8. PubMed ID: 8500724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemoccult screening for colorectal cancer. An impact study on Sarasota, Florida.
    Bralow SP; Kopel J
    J Fla Med Assoc; 1979 Sep; 66(9):915-9. PubMed ID: 479801
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemoccult screening for colorectal neoplasms: report of a pilot project.
    Norfleet RG; Roberts RC
    Wis Med J; 1979 Jan; 78(1):25-6. PubMed ID: 419765
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of a mass colorectal cancer screening program for cost-effectiveness.
    Johnson MG; Jolly PC
    Am J Surg; 1987 Sep; 154(3):261-3. PubMed ID: 3115125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemoccult screening for colorectal cancer: risks and benefits.
    Feldman JG
    N Y State J Med; 1986 Feb; 86(2):62-3. PubMed ID: 3456524
    [No Abstract]   [Full Text] [Related]  

  • 15. Reproducibility and diagnostic value of Hemoccult-II test. A colonoscopic evaluation in asymptomatic patients.
    Adamsen S; Kronborg O; Hage E; Fenger C
    Scand J Gastroenterol; 1985 Nov; 20(9):1073-7. PubMed ID: 4089518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biases in the assessment of colorectal cancer screening programmes using hemoccult.
    Dickinson JA
    Aust N Z J Surg; 1982 Dec; 52(6):622-5. PubMed ID: 6962733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Colonic and rectal cancer screening using fecal occult blood analysis (our experience)].
    Trignano M; Uzzau A; Nonnis R; Terrosu G; Noce L; Farris A
    Chir Ital; 1986 Oct; 38(5):511-8. PubMed ID: 3815641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemoccult screening for colorectal cancer in Missouri.
    Linne JH; Fulbeck CT; Butt JH; Huston JD; Butt MT; Jaco D
    Mo Med; 1983 Jun; 80(6):309-12. PubMed ID: 6877226
    [No Abstract]   [Full Text] [Related]  

  • 19. Fecal alpha 1-antitrypsin detection of colorectal neoplasia. An evaluation using HemoQuant.
    Moran A; Robinson M; Lawson N; Stanley J; Jones AF; Hardcastle JD
    Dig Dis Sci; 1995 Dec; 40(12):2522-5. PubMed ID: 8536506
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.